Ascelia Pharma AB
STO:ACE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascelia Pharma AB
STO:ACE
|
SE |
|
B
|
Bougainville Copper Ltd
ASX:BOC
|
PG |
|
Interparfums SA
PAR:ITP
|
FR |
|
M
|
Mapspeople A/S
CSE:MAPS
|
DK |
|
Nippon Tungsten Co Ltd
TSE:6998
|
JP |
|
Albis Leasing AG
XETRA:ALG
|
DE |
|
UP Fintech Holding Ltd
NASDAQ:TIGR
|
CN |
|
Vanquis Banking Group PLC
LSE:VANQ
|
UK |
|
Editas Medicine Inc
NASDAQ:EDIT
|
US |
|
Television Francaise 1 SA
PAR:TFI
|
FR |
|
P
|
Pernod Ricard SA
F:PER
|
FR |
|
GMK Noril'skiy Nikel' PAO
MOEX:GMKN
|
RU |
|
Adams PLC
LSE:ADA
|
IM |
|
Meta Platforms Inc
BMV:META
|
US |
|
Access Intelligence PLC
LSE:ACC
|
UK |
|
M
|
Medibank Private Ltd
F:MPV
|
AU |
|
Aimia Inc
TSX:AIM
|
CA |
|
F
|
Fraport Frankfurt Airport Services Worldwide AG
XMUN:FRA
|
DE |
|
J
|
John Menzies PLC
F:B3N
|
UK |
|
Service Stream Ltd
ASX:SSM
|
AU |
Wall Street
Price Targets
ACE Price Targets Summary
Ascelia Pharma AB
According to Wall Street analysts, the average 1-year price target for
ACE
is 8.16 SEK
with a low forecast of 6.57 SEK and a high forecast of 9.98 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACE's stock price target?
Price Target
8.16
SEK
According to Wall Street analysts, the average 1-year price target for
ACE
is 8.16 SEK
with a low forecast of 6.57 SEK and a high forecast of 9.98 SEK.